<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02816073</url>
  </required_header>
  <id_info>
    <org_study_id>12-0079</org_study_id>
    <nct_id>NCT02816073</nct_id>
  </id_info>
  <brief_title>Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy</brief_title>
  <official_title>Single-session Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy - a Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United Christian Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>United Christian Hospital</source>
  <brief_summary>
    <textblock>
      A randomized study to assess the safety and efficacy of single-session pan-retinal
      photocoagulation (PRP) using Pattern Scan Laser (PASCAL) in proliferative diabetic
      retinopathy (PDR) - 1,700 shots vs 2,500 shots
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Regression of neovascularization</measure>
    <time_frame>3 months</time_frame>
    <description>Fluorescein angiogram assessment by independent observer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Activity of neovascularization</measure>
    <time_frame>3 months</time_frame>
    <description>Descriptive analysis of fundus fluorescein angiogram by independent observer into 4 categories: no leakage, reduced leakage, same leakage, increased leakage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>1 week, 1 month, 3 months, 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>1 week, 1 month, 3 months, 6 months</time_frame>
    <description>choroidal detachment, exudative retinal detachment, retinal breaks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central foveal thickness</measure>
    <time_frame>1 week</time_frame>
    <description>Measured by spectral domain optical coherence tomography (Heidelberg Spectralis)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retreatment rate</measure>
    <time_frame>6 months</time_frame>
    <description>Patients requiring retreatment with pan-retinal photocoagulation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <condition>Lasers</condition>
  <condition>Treatment Outcome</condition>
  <arm_group>
    <arm_group_label>1,700</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive 1,700 (+/- 5%) laser shots in a single session of pan-retinal photocoagulation using pattern scanning laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2,500</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive 2,500 (+/- 5%) laser shots in a single session of pan-retinal photocoagulation using pattern scanning laser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pan-retinal photocoagulation using pattern scanning laser</intervention_name>
    <description>Patients receive the designated number of laser shots of pan-retinal photocoagulation with pattern scanning laser in a single session</description>
    <arm_group_label>1,700</arm_group_label>
    <arm_group_label>2,500</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All treatment-na√Øve patients with proliferative diabetic retinopathy (PDR) who
             attended our ophthalmic clinic from 1st December 2012 to 30th November

        Exclusion Criteria:

          -  significant media opacity affecting laser uptake (e.g. corneal opacity, mature
             cataract, dense vitreous haemorrhage)

          -  any pre-existing ocular disorders resulting in visual impairment (e.g. retinal
             degenerations, maculopathies, primary glaucoma and other optic neuropathies)

          -  those who received previous retinal laser treatment, intravitreal injections or
             intraocular surgeries

          -  clinically significant macular oedema on clinical examination.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth KW Li, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>United Christian Hospital; The University of Hong Kong</affiliation>
  </overall_official>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2016</study_first_posted>
  <last_update_submitted>June 28, 2016</last_update_submitted>
  <last_update_submitted_qc>June 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>United Christian Hospital</investigator_affiliation>
    <investigator_full_name>Chung-yee Chung</investigator_full_name>
    <investigator_title>Associate Consultant</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

